+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect on plasma cholesterol of dietary advice in secondary and primary prevention of arteriosclerotic cardiovascular disease



Effect on plasma cholesterol of dietary advice in secondary and primary prevention of arteriosclerotic cardiovascular disease



Naringsforskning 21(2): 107-116



To 258 men 36 to 57 years old who had had coronary infarction, of whom 193 completed the study, individual advice on a diet suitable for healthy adults was given, although diet histories revealed generally that their average intakes of nutrients before infarction differed little from the Swedish norm. At follow-up interviews 1 and 2 years after infarction the 24-h recall method was used.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 000358869

Download citation: RISBibTeXText


Related references

Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV. European Journal of Preventive Cardiology 2019: 2047487319838218, 2019

Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Annals of the new York Academy of Sciences 1290: 37-51, 2013

Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2004(1): Cd003656, 2004

Comparison of uptake and predictors of adherence in primary and secondary prevention of cardiovascular disease in a community-based cardiovascular prevention programme (MyAction Westminster). Journal of Public Health 36(4): 644-650, 2014

Simple method of assessing the effect of dietary advice to reduce plasma cholesterol. Preventive Medicine 10(3): 364-370, 1981

Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis. Zhonghua Xin Xue Guan Bing Za Zhi 44(8): 665-670, 2016

Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up. Circulation 136(20): 1878-1891, 2017

Heartwatch: the effect of a primary care-delivered secondary prevention programme for cardiovascular disease on medication use and risk factor profiles. European Journal of Cardiovascular Prevention and Rehabilitation 18(1): 129-135, 2011

The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 2. Implications for heart disease prevention in Australia. Medical Journal of Australia 155(10): 670-674, 1991

Evidence-based medicine should be practiced for primary prevention and secondary prevention of cardiovascular disease. Clinical Cardiology 35(5): 257-258, 2012

Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease. Journal of Cardiovascular Pharmacology and Therapeutics 19(1): 45-52, 2014

Role of dietary intervention in the primary prevention of coronary heart disease. Individuals with high-normal or elevated serum cholesterol levels should be placed on cholesterol-lowering diets. Cardiology 74(1): 2-21, 1987

Cardiovascular Disease in Women: Primary and Secondary Cardiovascular Disease Prevention. Obstetrics and Gynecology Clinics of North America 43(2): 265-285, 2016

Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. Bmj 349: G4356, 2014

The Mediterranean and other Dietary Patterns in Secondary Cardiovascular Disease Prevention: A Review. Current Vascular Pharmacology 14(5): 442-451, 2016